Journal of Pharmacology and Experimental Therapeutics: 255 (2)

November 01, 1990; Volume 255,Issue 2

You have access
L-tyrosine potentiates the anorexia induced by mixed-acting sympathomimetic drugs in hyperphagic rats.
K M Hull and T J Maher

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 403-409;
You have access
Suppressive effects of morphine pellet implants on in vivo parameters of immune function.
H U Bryant and R E Roudebush

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 410-414;
You have access
CRE 10904 [2-(p-fluorophenoxy), 1-(o-hydroxyphenyl)-ethane]: a new diuretic and antihypertensive drug acting by in vivo sulfation.
R P Garay, J P Labaune, D Mesangeau, C Nazaret, T Imbert and G Moinet

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 415-422;
You have access
Calcitonin gene-related peptide is the endogenous mediator of nonadrenergic-noncholinergic vasodilation in rat mesentery.
S P Han, L Naes and T C Westfall

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 423-428;
You have access
Modulation of ATP-sensitive K+ channel activity and contractile behavior in mammalian ventricle by the potassium channel openers cromakalim and RP49356.
C Ripoll, W J Lederer and C G Nichols

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 429-435;
You have access
Effect of DQ-2556, a new cephalosporin, on organic ion transport in renal plasma membrane vesicles from the dog, rabbit and rat.
P P Sokol

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 436-441;
You have access
In vivo treatment with benzodiazepines inhibits murine phagocyte oxidative metabolism and production of interleukin 1, tumor necrosis factor and interleukin-6.
F Zavala, V Taupin and B Descamps-Latscha

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 442-450;
You have access
Opiate-receptor antagonist improves metabolic recovery and limits neurochemical alterations associated with reperfusion after global brain ischemia in rats.
A I Faden, R Shirane, L H Chang, T L James, M Lemke and P R Weinstein

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 451-458;
You have access
Mechanisms of potassium channel block in rat alveolar epithelial cells.
E R Jacobs and T E DeCoursey

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 459-472;
You have access
Endothelium-mediated effects of N-substituted arginines on the isolated perfused rat kidney.
M Y Farhat, P W Ramwell and G Thomas

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 473-477;
You have access
Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymethamphetamine in rats.
C J Schmidt, G M Abbate, C K Black and V L Taylor

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 478-483;
You have access
Protective effect of a novel calcium blocker, S-312-d, on ischemic acute renal failure in rat.
T Shimizu, T Kawabata and M Nakamura

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 484-490;
You have access
Renal disposition and effects of naproxen and its l-enantiomer in the isolated perfused rat kidney.
P G Cox, W M Moons, F G Russel and C A van Ginneken

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 491-496;
You have access
Neuromodulatory effects of atrial natriuretic factor are independent of guanylate cyclase in adrenergic neuronal pheochromocytoma cells.
J G Drewett, R J Ziegler and G J Trachte

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 497-503;
You have access
A new metabolic pathway of morphine: in vivo and in vitro formation of morphinone and morphine-glutathione adduct in guinea pig.
Y Kumagai, T Todaka and S Toki

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 504-510;
You have access
Pharmacology of pravadoline: a new analgesic agent.
D R Haubrich, S J Ward, E Baizman, M R Bell, J Bradford, R Ferrari, M Miller, M Perrone, A K Pierson and J K Saelens

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 511-522;
You have access
Naloxone potentiation of cardiovascular responses to sympathomimetic amines in the rat.
M Feria, C Alvarez, J Domínguez, A Sánchez and J Boada

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 523-528;
You have access
Stereoselective and nonstereoselective effects of ibuprofen enantiomers on mitochondrial beta-oxidation of fatty acids.
E Freneaux, B Fromenty, A Berson, G Labbe, C Degott, P Letteron, D Larrey and D Pessayre

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 529-535;
You have access
Antagonist-induced up-regulation of the putative epsilon opioid receptor in rat brain: comparison with kappa, mu and delta opioid receptors.
A L Giordano, B Nock and T J Cicero

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 536-540;
You have access
Pharmacokinetics, anticonvulsant efficacy and adverse effects of the beta-carboline abecarnil, a novel ligand for benzodiazepine receptors, after acute and chronic administration in dogs.
W Löscher, D Hönack, R Scherkl, A Hashem and H H Frey

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 541-548;
You have access
A comparison of the effects of cholinergic and dopaminergic agents on scopolamine-induced hyperactivity in mice.
H E Shannon and S C Peters

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 549-553;
You have access
On the metallothionein, glutathione and cysteine relationship in rat liver.
J Hidalgo, J S Garvey and A Armario

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 554-564;
You have access
Modulation of ligand binding to leukotriene B4 receptors on guinea pig lung membranes by sulfhydryl modifying reagents.
R C Falcone and D Aharony

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 565-571;
You have access
Effect of the leukotriene B4 receptor antagonist SC-41930 on colonic inflammation in rat, guinea pig and rabbit.
D J Fretland, D Widomski, B S Tsai, J M Zemaitis, S Levin, S W Djuric, R L Shone and T S Gaginella

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 572-576;
You have access
Effect of aging on hepatic biotransformation in female Fischer 344 rats: changes in sulfotransferase activities are consistent with known gender-related changes in pituitary growth hormone secretion in aging animals.
R E Galinsky, D H Johnson, R E Kane and M R Franklin

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 577-583;
You have access
Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2).
P C Wong, S D Hart, A M Zaspel, A T Chiu, R J Ardecky, R D Smith and P B Timmermans

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 584-592;
You have access
SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies.
P Polster, B Christophe, M Van Damme, A Houlliche and P Chatelain

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 593-599;
You have access
SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes.
P Nokin, M Clinet, P Beaufort, L Meysmans, R Laruel and P Chatelain

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 600-607;
You have access
Effects of TRH-analog treatment on tissue cations, phospholipids and energy metabolism after spinal cord injury.
A I Faden, S W Yum, M Lemke and R Vink

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 608-614;
You have access
Cimetidine transport in isolated brush border membrane vesicles from bovine choroid plexus.
M T Whittico, Y A Gang and K M Giacomini

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 615-623;
You have access
Characterization of the lipophilicity of natural and synthetic analogs of delta 9-tetrahydrocannabinol and its relationship to pharmacological potency.
B F Thomas, D R Compton and B R Martin

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 624-630;
You have access
Dipyridamole inhibition of HCO3(-)-Cl- exchange in human erythrocytes.
T A Heming, C G Vanoye and A Bidani

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 631-635;
You have access
Opioid agonist and antagonist antinociceptive properties of [D-Ala2,Leu5,Cys6]enkephalin: selective actions at the deltanoncomplexed site.
J A Qi, W D Bowen, H I Mosberg, R B Rothman and F Porreca

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 636-641;
You have access
Genetically determined steady-state interaction between encainide and quinidine in patients with arrhythmias.
J Turgeon, H N Pavlou, W Wong, C Funck-Brentano and D M Roden

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 642-649;
You have access
Functional interactions in smooth muscle: kinetic characterization of the relaxation and desensitization responses to a beta adrenergic agonist in the rabbit aorta.
S A Keitz, R Osman, W P Clarke, J Goldfarb and S Maayani

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 650-656;
You have access
A specific gamma-hydroxybutyrate receptor ligand possesses both antagonistic and anticonvulsant properties.
M Maitre, V Hechler, P Vayer, S Gobaille, C D Cash, M Schmitt and J J Bourguignon

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 657-663;
You have access
Evidence that peptidoleukotriene is a prerequisite for antigen-dependent thromboxane synthesis in IgG1-passively sensitized guinea pig lungs.
J B Cheng, J S Pillar, M J Conklyn, R Breslow, J T Shirley and H J Showell

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 664-671;
You have access
Stable circadian mechanisms of toxicity of two platinum analogs (cisplatin and carboplatin) despite repeated dosages in mice.
N A Boughattas, F Lévi, C Fournier, B Hecquet, G Lemaigre, A Roulon, G Mathé and A Reinberg

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 672-679;
You have access
Both d-cis- and l-cis-diltiazem have anti-ischemic action in the isolated, perfused working rat heart.
Y Nasa, K Ichihara and Y Abiko

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 680-689;
You have access
The activity of zolpidem and other hypnotics within the gamma-aminobutyric acid (GABAA) receptor supramolecular complex, as determined by 35S-t-butylbicyclophosphorothionate (35S-TBPS) binding to rat cerebral cortex membranes.
G K Lloyd, G Danielou and F Thuret

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 690-696;
You have access
Selective inhibition of relaxation of guinea-pig trachea by charybdotoxin, a potent Ca(++)-activated K+ channel inhibitor.
T R Jones, L Charette, M L Garcia and G J Kaczorowski

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 697-706;
You have access
Influence of chronic alcohol administration on representative indices of puberty and sexual maturation in male rats and the development of their progeny.
T J Cicero, M L Adams, L O'Connor, B Nock, E R Meyer and D Wozniak

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 707-715;
You have access
Pharmacodynamic characterization of posture-related diuretic and saluretic responses to furosemide in humans.
T Okaniwa, H Echizen, T Ishizaki, M Kasao and T Iizuka

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 716-723;
You have access
Pharmacokinetics of recombinant human granulocyte colony-stimulating factor studied in the rat by a sandwich enzyme-linked immunosorbent assay.
H Tanaka and T Tokiwa

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 724-729;
You have access
Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval II.
K C Kirby, M L Stitzer and S J Heishman

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 730-737;
You have access
Use-dependent effects of lidocaine in neonatal and adult ventricular myocardium.
C D Jeck and M R Rosen

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 738-743;
You have access
Precipitated abstinence in orally dosed benzodiazepine-dependent dogs.
W R Martin, J W Sloan and E Wala

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 744-755;
You have access
Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils.
J E Bleasdale, N R Thakur, R S Gremban, G L Bundy, F A Fitzpatrick, R J Smith and S Bunting

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 756-768;
You have access
Naloxone benzoylhydrazone (NalBzoH) analgesia.
D Paul, J A Levison, D H Howard, C G Pick, E F Hahn and G W Pasternak

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 769-774;
You have access
Neurotensin-dopamine interactions in the substantia nigra of the rat brain.
K M Merchant, L G Bush, J W Gibb and G R Hanson

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 775-780;
You have access
Augmentation of release of gastric somatostatin-like immunoreactivity by adenosine, adenosine triphosphate and their analogs.
Y N Kwok, C McIntosh and J Brown

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 781-788;
You have access
Effects of benzodiazepines on passive avoidance response and latent learning in mice: relationship to benzodiazepine receptors and the cholinergic neuronal system.
T Nabeshima, K Tohyama, K Ichihara and T Kameyama

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 789-794;
You have access
Peripheral opioid receptors mediating antinociception in inflammation. Evidence for activation by enkephalin-like opioid peptides after cold water swim stress.
C G Parsons and A Herz

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 795-802;
You have access
Augmentation of morphine-induced changes in brain monoamine metabolism after chronic naltrexone treatment.
L Ahtee, L M Attila and K R Carlson

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 803-808;
You have access
Fate of tritiated 6-fluorodopamine in rats: a false neurotransmitter for positron emission tomographic imaging of sympathetic innervation and function.
P C Chang, K Szemeredi, E Grossman, I J Kopin and D S Goldstein

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 809-817;
You have access
Possible involvement of ATP-sensitive K+ channels in the relaxant response of dog middle cerebral artery to cromakalim.
K Masuzawa, M Asano, T Matsuda, Y Imaizumi and M Watanabe

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 818-825;
You have access
Kinetic analysis of the opiate antagonist cyclofoxy in rat brain: simultaneous infusion of active and inactive enantiomers.
R Kawai, Y Sawada, M Channing, B Dunn, A H Newman, K C Rice and R G Blasberg

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 826-835;
You have access
Effects of cromakalim and pinacidil on large epicardial and small coronary arteries in conscious dogs.
J F Giudicelli, C D la Rochelle and A Berdeaux

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 836-842;
You have access
Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
N M Appel, W M Mitchell, R K Garlick, R A Glennon, M Teitler and E B De Souza

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 843-857;
You have access
Protection against gentamicin-induced early renal alterations (phospholipidosis and increased DNA synthesis) by coadministration of poly-L-aspartic acid.
D Beauchamp, G Laurent, P Maldague, S Abid, B K Kishore and P M Tulkens

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 858-866;
You have access
Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. I. Polyaspartic acid binds gentamicin and displaces it from negatively charged phospholipid layers in vitro.
B K Kishore, Z Kállay, P Lambricht, G Laurent and P M Tulkens

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 867-874;
You have access
Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. II. Comparative in vitro and in vivo studies with poly-L-aspartic, poly-L-glutamic and poly-D-glutamic acids.
B K Kishore, P Lambricht, G Laurent, P Maldague, R Wagner and P M Tulkens

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 875-885;
You have access
On the ability of endogenous adenosine to regulate purine nucleoside receptor binding of antagonists in smooth muscle membranes.
W P Schiemann, J M Walther and I L Buxton

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 886-892;
You have access
Evaluation of cationized rat albumin as a potential blood-brain barrier drug transport vector.
W M Pardridge, D Triguero, J Buciak and J Yang

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 893-899;
You have access
Nonopioid actions of the kappa-opioid receptor agonists, U 50488H and U 69593 on electrophysiologic properties of hippocampal CA3 neurons in vitro.
C Alzheimer and G ten Bruggencate

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 900-905;
You have access
Prevention of hippocampus neuronal damage in ischemic gerbils by a novel lipid peroxidation inhibitor (quinazoline derivative).
H Hara and K Kogure

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 906-913;
You have access
Levodopa delivery from controlled-release polymer matrix: delivery of more than 600 days in vitro and 225 days of elevated plasma levels after subcutaneous implantation in rats.
B A Sabel, P Dominiak, W Häuser, M J During and A Freese

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 914-922;
You have access
Resiniferatoxin: an ultrapotent selective modulator of capsaicin-sensitive primary afferent neurons.
J Szolcsanyi, A Szallasi, Z Szallasi, F Joo and P M Blumberg

Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 923-928;

Main menu

User menu

Search

Table of Contents

In this issue

Navigate

More Information

ASPET's Other Journals